Does the media prefer XRAY or COO?

In the previous week, Cooper Companies had 33 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 42 mentions for Cooper Companies and 9 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.70 beat DENTSPLY SIRONA's score of 0.10 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Cooper Companies 12 Very Positive mention(s) 8 Positive mention(s) 11 Neutral mention(s) 8 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to XRAY or MMSI?

In the previous week, DENTSPLY SIRONA had 8 more articles in the media than Merit Medical Systems. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 1 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.73 beat DENTSPLY SIRONA's score of 0.10 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to NVST or XRAY?

In the previous week, Envista had 9 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 18 mentions for Envista and 9 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 0.34 beat DENTSPLY SIRONA's score of 0.10 indicating that Envista is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer BLCO or XRAY?

In the previous week, DENTSPLY SIRONA had 5 more articles in the media than Bausch + Lomb. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 4 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 0.43 beat DENTSPLY SIRONA's score of 0.10 indicating that Bausch + Lomb is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch + Lomb 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer XRAY or ICUI?

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than ICU Medical. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 7 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.66 beat DENTSPLY SIRONA's score of 0.10 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral ICU Medical 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DENTSPLY SIRONA (XRAY) Competitors

$9.78 -0.17 (-1.71%)

Closing price 04:00 PM Eastern

Extended Trading

$9.85 +0.07 (+0.72%)

As of 07:30 PM Eastern

Compare

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

Should you buy DENTSPLY SIRONA stock or one of its competitors? DENTSPLY SIRONA's main competitors and comparable companies include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), Bausch + Lomb (BLCO), and ICU Medical (ICUI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does DENTSPLY SIRONA compare to Cooper Companies?

DENTSPLY SIRONA (NASDAQ:XRAY) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.53	-$598M	-$2.75	N/A
Cooper Companies	$4.09B	2.61	$374.90M	$2.93	19.14

DENTSPLY SIRONA currently has a consensus price target of $13.31, indicating a potential upside of 36.07%. Cooper Companies has a consensus price target of $71.47, indicating a potential upside of 27.46%. Given DENTSPLY SIRONA's higher possible upside, equities research analysts plainly believe DENTSPLY SIRONA is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cooper Companies	2 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.16

DENTSPLY SIRONA has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

In the previous week, Cooper Companies had 33 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 42 mentions for Cooper Companies and 9 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.70 beat DENTSPLY SIRONA's score of 0.10 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Cooper Companies	12 Very Positive mention(s)	8 Positive mention(s)	11 Neutral mention(s)	8 Negative mention(s)	1 Very Negative mention(s)	Positive

Cooper Companies has a net margin of 13.46% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Cooper Companies	13.46%	10.90%	7.24%

Summary

Cooper Companies beats DENTSPLY SIRONA on 12 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

DENTSPLY SIRONA (NASDAQ:XRAY) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, DENTSPLY SIRONA had 8 more articles in the media than Merit Medical Systems. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 1 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.73 beat DENTSPLY SIRONA's score of 0.10 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Merit Medical Systems has a net margin of 9.22% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Merit Medical Systems	9.22%	13.75%	8.10%

Merit Medical Systems has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.53	-$598M	-$2.75	N/A
Merit Medical Systems	$1.52B	3.43	$128.49M	$2.42	35.98

DENTSPLY SIRONA has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

DENTSPLY SIRONA currently has a consensus price target of $13.31, suggesting a potential upside of 36.07%. Merit Medical Systems has a consensus price target of $100.00, suggesting a potential upside of 14.85%. Given DENTSPLY SIRONA's higher possible upside, equities analysts plainly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Envista presently has a consensus target price of $29.86, indicating a potential upside of 25.23%. DENTSPLY SIRONA has a consensus target price of $13.31, indicating a potential upside of 36.07%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.53
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envista has a net margin of 3.33% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	3.33%	7.88%	4.33%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.41	$47M	$0.58	41.11
DENTSPLY SIRONA	$3.68B	0.53	-$598M	-$2.75	N/A

In the previous week, Envista had 9 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 18 mentions for Envista and 9 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 0.34 beat DENTSPLY SIRONA's score of 0.10 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Envista beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

In the previous week, DENTSPLY SIRONA had 5 more articles in the media than Bausch + Lomb. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 4 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 0.43 beat DENTSPLY SIRONA's score of 0.10 indicating that Bausch + Lomb is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Bausch + Lomb has a net margin of -3.21% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-3.21%	4.14%	1.93%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.5% of Bausch + Lomb shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Bausch + Lomb presently has a consensus price target of $19.15, indicating a potential upside of 12.25%. DENTSPLY SIRONA has a consensus price target of $13.31, indicating a potential upside of 36.07%. Given DENTSPLY SIRONA's higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Bausch + Lomb has higher revenue and earnings than DENTSPLY SIRONA. Bausch + Lomb is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.20	-$360M	-$0.48	N/A
DENTSPLY SIRONA	$3.68B	0.53	-$598M	-$2.75	N/A

Bausch + Lomb has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market.

Summary

Bausch + Lomb beats DENTSPLY SIRONA on 10 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

DENTSPLY SIRONA (NASDAQ:XRAY) and ICU Medical (NASDAQ:ICUI) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than ICU Medical. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 7 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.66 beat DENTSPLY SIRONA's score of 0.10 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
ICU Medical	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has a net margin of 1.39% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
ICU Medical	1.39%	7.91%	4.17%

DENTSPLY SIRONA currently has a consensus price target of $13.31, suggesting a potential upside of 36.07%. ICU Medical has a consensus price target of $192.80, suggesting a potential upside of 18.05%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

DENTSPLY SIRONA has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ICU Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.53	-$598M	-$2.75	N/A
ICU Medical	$2.23B	1.83	$730K	$1.18	138.41

Summary

ICU Medical beats DENTSPLY SIRONA on 11 of the 17 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.98B	$5.52B	$7.21B	$13.10B
Dividend Yield	N/A	1.79%	2.53%	13.00%
P/E Ratio	-3.56	25.27	274.58	25.69
Price / Sales	0.53	43.07	639.38	80.65
Price / Cash	1.66	32.79	76.31	52.02
Price / Book	1.46	5.78	10.44	6.32
Net Income	-$598M	$151.55M	$3.49B	$359.73M
7 Day Performance	-3.55%	1.49%	0.51%	1.35%
1 Month Performance	-10.44%	-3.63%	-3.38%	-3.68%
1 Year Performance	-24.54%	6.20%	16.04%	5.56%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	3.1968 of 5 stars	$9.78 -1.7%	$13.31 +36.1%	-24.8%	$1.98B	$3.68B	N/A	14,000
COO Cooper Companies	4.5182 of 5 stars	$54.22 +0.6%	$71.47 +31.8%	-18.7%	$10.25B	$4.24B	18.51	15,000	Trending News Analyst Revision
MMSI Merit Medical Systems	3.327 of 5 stars	$87.02 +0.8%	$100.00 +14.9%	+4.4%	$5.16B	$1.52B	35.96	7,500	Positive News
NVST Envista	3.9709 of 5 stars	$25.79 +0.9%	$29.71 +15.2%	+15.8%	$4.10B	$2.86B	44.46	12,000	Positive News
BLCO Bausch + Lomb	3.5764 of 5 stars	$17.64 +2.3%	$19.15 +8.6%	+13.5%	$6.16B	$5.32B	N/A	13,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Do institutionals & insiders believe in XRAY or COO?

Which has preferable earnings and valuation, XRAY or COO?

Do analysts rate XRAY or COO?

Which has more volatility and risk, XRAY or COO?

Does the media prefer XRAY or COO?

Is XRAY or COO more profitable?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Do insiders and institutionals believe in XRAY or MMSI?

Does the media refer more to XRAY or MMSI?

Is XRAY or MMSI more profitable?

Which has stronger valuation and earnings, XRAY or MMSI?

Which has more volatility and risk, XRAY or MMSI?

Do analysts prefer XRAY or MMSI?

Summary

How does DENTSPLY SIRONA compare to Envista?

Do analysts recommend NVST or XRAY?

Is NVST or XRAY more profitable?

Which has stronger earnings and valuation, NVST or XRAY?

Does the media refer more to NVST or XRAY?

Which has more volatility and risk, NVST or XRAY?

Do insiders & institutionals have more ownership in NVST or XRAY?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Does the media prefer BLCO or XRAY?

Is BLCO or XRAY more profitable?

Do insiders & institutionals believe in BLCO or XRAY?

Do analysts rate BLCO or XRAY?

Which has higher valuation & earnings, BLCO or XRAY?

Which has more risk & volatility, BLCO or XRAY?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Does the media prefer XRAY or ICUI?

Is XRAY or ICUI more profitable?

Do analysts recommend XRAY or ICUI?

Which has more risk and volatility, XRAY or ICUI?

Do insiders and institutionals hold more shares of XRAY or ICUI?

Which has preferable valuation and earnings, XRAY or ICUI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools